Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance

BACKGROUND: Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Duffy, David J., Krstic, Aleksandar, Halasz, Melinda, Schwarzl, Thomas, Konietzny, Anja, Iljin, Kristiina, Higgins, Desmond G., Kolch, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303304/
https://www.ncbi.nlm.nih.gov/pubmed/28187790
http://dx.doi.org/10.1186/s13073-017-0407-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303304/
https://www.ncbi.nlm.nih.gov/pubmed/28187790
http://dx.doi.org/10.1186/s13073-017-0407-3

Ejemplares similares